Robert Seifert

3.4k total citations · 1 hit paper
122 papers, 1.9k citations indexed

About

Robert Seifert is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert Seifert has authored 122 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Radiology, Nuclear Medicine and Imaging, 63 papers in Pulmonary and Respiratory Medicine and 28 papers in Oncology. Recurrent topics in Robert Seifert's work include Radiopharmaceutical Chemistry and Applications (44 papers), Medical Imaging Techniques and Applications (43 papers) and Prostate Cancer Treatment and Research (42 papers). Robert Seifert is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (44 papers), Medical Imaging Techniques and Applications (43 papers) and Prostate Cancer Treatment and Research (42 papers). Robert Seifert collaborates with scholars based in Germany, Switzerland and United States. Robert Seifert's co-authors include Kambiz Rahbar, Michael Schäfers, Matthias Weckesser, Ken Herrmann, Katharina Kessel, Wolfgang P. Fendler, Martin Bögemann, Katrin Schlack, Martin Boegemann and David Kersting and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Robert Seifert

116 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)

2023 127 citations Robert Seifert, Steven P. Rowe et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Seifert Germany	24	1.2k	1.1k	391	237	197	122	1.9k
Vera Wenter Germany	22	968 0.8×	744 0.7×	258 0.7×	184 0.8×	167 0.8×	51	1.7k
Helmut Dittmann Germany	20	994 0.8×	585 0.6×	371 0.9×	323 1.4×	157 0.8×	84	1.7k
Claudio Landoni Italy	25	1.4k 1.2×	1.0k 1.0×	317 0.8×	193 0.8×	267 1.4×	87	2.4k
Niklaus Schaefer Switzerland	28	1.3k 1.1×	734 0.7×	519 1.3×	142 0.6×	283 1.4×	117	2.5k
Margarita Kirienko Italy	28	1.8k 1.5×	913 0.9×	489 1.3×	170 0.7×	237 1.2×	69	2.3k
Andrei Todica Germany	21	840 0.7×	460 0.4×	384 1.0×	109 0.5×	196 1.0×	105	1.5k
Kimiichi Uno Japan	21	1.2k 1.0×	947 0.9×	301 0.8×	212 0.9×	190 1.0×	57	1.8k
Nanda C. Krak Netherlands	13	1.0k 0.8×	367 0.3×	341 0.9×	283 1.2×	258 1.3×	22	1.5k
Edward Hsiao Australia	19	676 0.6×	816 0.8×	361 0.9×	82 0.3×	129 0.7×	54	1.4k
Susanne Klutmann Germany	25	941 0.8×	750 0.7×	324 0.8×	96 0.4×	420 2.1×	98	2.0k

Countries citing papers authored by Robert Seifert

Since Specialization

Citations

This map shows the geographic impact of Robert Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Seifert more than expected).

Fields of papers citing papers by Robert Seifert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Seifert. The network helps show where Robert Seifert may publish in the future.

Co-authorship network of co-authors of Robert Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Seifert. A scholar is included among the top collaborators of Robert Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Seifert. Robert Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercolli, Lorenzo, Tilman Läppchen, Michael Amon, et al.. (2025). In vivo voxel-wise positronium lifetime imaging of thyroid cancer using clinically routine I-124 PET/CT. Homo Politicus (Academy of Humanities and Economics in Lodz). 2. 100017–100017.

Darr, Christopher, Elai Davicioni, Kuangyu Shi, et al.. (2025). Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy. Theranostics. 15(18). 9447–9458.

Seifert, Robert, George Prenosil, Mike Sathekge, et al.. (2025). Optimizing theranostics chatbots with context-augmented large language models. Theranostics. 15(12). 5693–5704. 1 indexed citations

Li, Y, Ming Zhou, Xiaomei Gao, et al.. (2025). Using mpMRI, PSMA, and GRPR PET to Assess Focal Therapy Eligibility and Plan Treatment in Biopsy-proven Low-/Intermediate-risk Prostate Cancer: A Whole-mount Pathology-based Study. Clinical Nuclear Medicine. 50(5). 410–418. 1 indexed citations

Rathod, N., et al.. (2025). The Evolution of Artificial Intelligence in Nuclear Medicine. Seminars in Nuclear Medicine. 55(3). 313–327. 1 indexed citations

Song, Yangmeihui, Jimin Hong, Axel Rominger, et al.. (2025). FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview. Seminars in Nuclear Medicine. 55(5). 710–723. 2 indexed citations

Moskal, P., Aleksander Bilewicz, S. Parzych, et al.. (2025). Positronium Imaging: History, Current Status, and Future Perspectives. IEEE Transactions on Radiation and Plasma Medical Sciences. 9(8). 981–1001. 1 indexed citations

Pabst, Kim M., Viktor Grünwald, Kuangyu Shi, et al.. (2025). Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3199–3210. 1 indexed citations

Mercolli, Lorenzo, Pascal V. Grundler, S. Braccini, et al.. (2025). First positronium lifetime imaging with scandium-44 on a long axial field-of-view PET/CT. PubMed. 5. 1648621–1648621. 1 indexed citations

10.

Hong, Jimin, Sungwoo Bae, Robert Seifert, et al.. (2024). Deciphering the effects of radiopharmaceutical therapy in the tumor microenvironment of prostate cancer: an in-silico exploration with spatial transcriptomics. Theranostics. 14(18). 7122–7139. 13 indexed citations

11.

Seifert, Robert, Constantin Lapa, Wolfgang Weber, et al.. (2024). Safety and Efficacy of Extended Therapy with [¹⁷⁷Lu]Lu-PSMA: A German Multicenter Study. Journal of Nuclear Medicine. 65(6). 909–916. 16 indexed citations

12.

Seifert, Robert, et al.. (2024). Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands. Nuklearmedizin - NuclearMedicine. 64(1). 7–12. 1 indexed citations

13.

Pabst, Kim M., Marija Trajkovic‐Arsic, Phyllis F. Cheung, et al.. (2023). Superior Tumor Detection for⁶⁸Ga-FAPI-46 Versus¹⁸F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma. Journal of Nuclear Medicine. 64(7). 1049–1055. 32 indexed citations

14.

Kim, Moon, Robert Seifert, David Kersting, et al.. (2023). Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2196–2209. 12 indexed citations

15.

Weber, Manuel, et al.. (2023). Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors. Cancers. 15(14). 3581–3581. 6 indexed citations

16.

Kesch, Claudia, Wolfgang P. Fendler, Yang Liu, et al.. (2023). Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy. Journal for ImmunoTherapy of Cancer. 11(10). e007354–e007354. 4 indexed citations

17.

Seifert, Robert, Sazan Rasul, Maria Eveslage, et al.. (2023). A Prognostic Risk Score for Prostate Cancer Based on PSMA PET–derived Organ-specific Tumor Volumes. Radiology. 307(4). e222010–e222010. 21 indexed citations

18.

Pyka, Thomas, Federico Caobelli, Lale Umutlu, et al.. (2023). What Role Does PET/MRI Play in Musculoskeletal Disorders?. Seminars in Nuclear Medicine. 55(2). 277–289. 4 indexed citations

19.

Seifert, Robert, Andrei Gafita, Andrew F. Voter, et al.. (2023). Standardized PSMA-PET Imaging of Advanced Prostate Cancer. Seminars in Nuclear Medicine. 54(1). 60–68. 7 indexed citations

20.

Sibille, Ludovic, Robert Seifert, Nemanja Avramović, et al.. (2019). ¹⁸F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks. Radiology. 294(2). 445–452. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact